SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12B - Securities registration termination [Section 12(b)]:
SEC Accession No. 0001193125-21-023611
Filing Date
2021-02-01
Accepted
2021-02-01 06:40:58
Documents
1
Effectiveness Date
2021-02-01

Document Format Files

Seq Description Document Type Size
1 15-12B d106556d1512b.htm 15-12B 10963
  Complete submission text file 0001193125-21-023611.txt   11977
Mailing Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016 917-336-9310
Prevail Therapeutics Inc. (Filer) CIK: 0001714798 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12B | Act: 34 | File No.: 001-38939 | Film No.: 21574278
SIC: 2836 Biological Products, (No Diagnostic Substances)